[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Mizock et al., 1994 - Google Patents

Lactic acidosis in a patient with multiple myeloma.

Mizock et al., 1994

View PDF
Document ID
7608591463808048703
Author
Mizock B
Glass J
Publication year
Publication venue
Western journal of medicine

External Links

Snippet

Discussion The most common cause of lactic acidosis in patients with malignant neoplasms is tissue hypoperfusion due to hypovolemia, sepsis, or cardiac dysfunction.'Lactic acidosis occurring in patients with clinical evidence of poor tissue perfusion or oxygenation (such as …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules

Similar Documents

Publication Publication Date Title
Oelz et al. Nifedipine for high altitude pulmonary oedema
EP1499331B1 (en) Salt solution for colon cleansing
GANGULY et al. Renin-secreting Wilms' tumor with severe hypertension: report of a case and brief review of renin-secreting tumors
Williams et al. ECLS in pertussis: does it have a role?
Codling et al. Pulmonary fibrosis following therapy with melphalan for multiple myeloma
Tsuchiya et al. Thoracic duct cyst of the mediastinum
MacLaren et al. Successful use of ECMO in adults with life-threatening infections
Mizock et al. Lactic acidosis in a patient with multiple myeloma.
Adler et al. Massive hepatic hemorrhage associated with cardiopulmonary resuscitation
Riordan et al. Pulmonary oedema in bacterial shock
Khalid et al. Cardiovascular side effects of tyrosine kinase inhibitor ibrutinib (imbruvica) and interaction with direct oral anticoagulant
Rigby et al. Recovery following prolonged gram-negative shock and “shock lung”
Takahashi et al. Extended resection for lung cancer invading mediastinal organs
Poe et al. Acute respiratory distress syndrome with pulmonary calcification in two patients with B cell malignancies
Schwartz et al. An unusual anomaly of the coronary system: origin of the anterior (descending) interventricular artery from the pulmonary trunk
Tisi et al. Collapse of left lung induced by artificial airway
Chopra et al. Peritoneal dialysis for pulmonary oedema after acute myocardial infarction
Clark et al. Idiopathic pulmonary alveolar microlithiasis: A case report and brief review of the literature
De Koning et al. Respiratory failure in leptospirosis (Weil's disease)
Stäubli et al. Hyperventilation-induced changes of blood cell counts depend on hypocapnia
Yu et al. Respiratory failure in infants weighing 1000 g or less at birth
Wiklund et al. Gas exchange as monitored in mixed venous and arterial blood during experimental cardiopulmonary resuscitation
Ayzenberg, O., Silber, MH & Bortz Beriberi heart disease-a case report describing the haemodynamic features
Mitsuyasu et al. Failure of trimethoprim-sulfamethoxazole in the therapy of recurrent Pneumocystis carinii pneumonia
Özmert et al. Clinical characteristics of transient glucose intolerance during acute diarrhoea